Niemann-Pick Disease Type C: Integrating FDA-Approved Therapies and Best Practices in Patient Management

At the conclusion of this course, participants will be able to:

1. Explain the pathophysiology and diagnosis of Niemann-Pick Disease Type C (NPC), including the roles of NPC1 and NPC2 mutations, key clinical symptoms, and diagnostic methods such as biomarker screening and genetic testing.

2. Evaluate current and emerging treatment strategies, including FDA-approved therapies such as arimoclomol and miglustat, as well as novel approaches like gene therapy and substrate reduction therapy.

3. Implement multidisciplinary and supportive care approaches by recognizing the roles of various specialists and developing individualized care plans integrating pharmacologic treatment, rehabilitation therapies, and patient education.

4. Analyze real-world case studies to enhance clinical decision-making, address treatment initiation and medication adherence challenges, and evaluate strategies to improve patient quality of life and address psychosocial, financial, and ethical considerations.

Advancements in the treatment of Niemann-Pick Disease Type C (NPC) have transformed the therapeutic landscape, with the FDA approval of novel disease-modifying therapies offering new hope for patients. Healthcare professionals must stay informed about these developments to provide evidence-based care that optimizes patient outcomes. Understanding the mechanisms of action, indications, contraindications, and monitoring requirements of newly approved treatments such as arimoclomol and miglustat is essential for integrating these therapies into clinical practice. Additionally, the expanding pipeline of investigational treatments, including gene therapy and substrate reduction strategies, underscores the importance of staying current with emerging research. This course equips healthcare professionals with the knowledge needed to navigate the complexities of NPC management, ensuring early diagnosis, informed treatment decisions, and a multidisciplinary approach to patient care.